Interventional Radiology Products Market to Reach $8.02 Billion in Upcoming Years

What This Report Will Provide?

This study involved four major activities in estimating the current size of the interventional radiology products market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Expected Revenue Growth:

The global interventional radiology products market is expected to reach USD 8.02 Billion by 2021 from USD 6.35 Billion in 2016, at a CAGR of 4.8%.

Major Growth Boosters:

The major factors driving the growth of this market are rising incidence of chronic diseases, rising geriatric population, and increasing demand for minimally invasive surgeries. However, new players in the interventional radiology sector face significant entry barriers; this is a key challenge in the market.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=67681703

This report aims to provide detailed insights into the global interventional radiology products industry. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

The information mentioned in the report would benefit the buyer by helping them understand the market dynamics. In addition, the forecasts provided in the report will enable firms to understand the trends in this market and better position themselves to capitalize the growth opportunities.

Key Questions Addressed in The Report:

1. Who are the top 10 players operating in the global interventional radiology products market?
2. What are the drivers, restraints, opportunities, and challenges in the interventional radiology products Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of interventional radiology products in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Applications of Interventioinal Radiology:

Based on application, the market is segmented into cardiology, urology & nephrology, oncology, gastroenterology, neurology, orthopedics, and other applications. The oncology segment is expected to grow at the highest CAGR during the forecast period. The major factors driving the growth of this market segment are the increasing incidence of cancer and rising demand for minimally invasive procedures.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=67681703

Regional Growth Analysis:

The global interventional radiology products market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to dominate the global market in the forecast period. However, Asia is expected to witness the highest CAGR, with the growth in this market centred at China, Japan, and India. The increasing prevalence of chronic diseases and growing geriatric population in Asia are driving the growth of this region.

Key Players:

Key players in the interventional radiology products market include Abbott Vascular (U.S.), Boston Scientific Corporation (U.S.), Medtronic plc (Ireland), Cardinal Health (U.S.), B. Braun Melsungen AG (Germany), C.R Bard (U.S.), Biosensor International Group Ltd. (Singapore), Stryker Corporation (U.S.), Terumo Corporation (Japan), and Cook Medical Inc. (U.S.).